Miller Fisher syndrome is a very rare nerve disease that’s related to Guillain-Barré syndrome (GBS). Guillain-Barré syndrome affects about one in 100,000 people.

The European Task Force unveils critical updates on Guillain-Barré syndrome, highlighting new treatment strategies and diagnostic criteria for clinicians.

Guillain-Barré syndrome (GBS) is a rare nerve disorder that can occur after an infection. It develops due to an overreaction of the immune system. There are several types of GBS.

The prioritization of innovative drug development such as monoclonal antibodies by leading industries is one of the key trends emerging in the Guillain-Barre syndrome market.

Guillain-Barré syndrome is a rare autoimmune disorder. Educate yourself about its causes, symptoms, and treatment methodologies.

The Miller Fisher variant of GBS, consisting of paralysis in the eye muscles and dizziness, is more likely to reoccur than GBS.

The clinical trials described a case of GBS and a case of the GBS variant known as Miller-Fisher syndrome that occurred at 7 and 8 days, respectively, after vaccination.

Dear Dr. Roach: You have written about immunocompromised people before, but what about those of us who have immune systems that overreact instead of underperform, such as with Guillain-Barre syndrome?

India has for the first time reported several cases of Guillain-Barré Syndrome (GBS). There was an alarming rise in suspected cases of GBS, a rare but serious neurological disorder.

To the Editor: I should like to venture some objection to the main point made by Drs. Osler and Sidell in their article, "The Guillain–Barré Syndrome," in the May 12 issue of the Journal. They ...

CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with ...

Miller-Fisher tends to affect the upper body first, whereas Guillain-Barre typically affects the lower body and then spreads upwards.